Company intelligence / Profile preview

NewBreed

Ownership: Private
Development stage: Other

Overview

NewBreed leverages advanced tomato genetic resources and expertise developed at the Hebrew University of Jerusalem to improve crop traits. The company translates academic research into commercial applications for agriculture, focusing on enhancing yield, disease resistance, and other valuable characteristics in tomatoes.

Therapeutic areas: Other
Modalities: Plant breedingGenetic resource utilization
Industry: Agriculture & AgTech

Partnerships

Hebrew University of Jerusalem (Prof. Dani Zamir’s laboratory)

Beyond the preview

Go deeper on NewBreed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NewBreed.

Explore the full profile